baber/WOPTO huggingface dataset:
Patent MA-38169-B2 (MA)
Title: Ciclésonide pour le traitement d'une maladie des voies respiratoires chez les chevaux
Inventor: ALBRECHT BALAZS
IPC: A61K31/573
Filed: 2013-12-18
Abstract: L'invention concerne le domaine de la médecine, en particulier le domaine de la médecine vétérinaire. La présente invention concerne des glucocorticoïdes, en particulier le ciclésonide ou un dérivé pharmaceutiquement acceptable de celui-ci, pour le traitement d'une maladie des voies respiratoires chez les chevaux, telles qu'une maladie pulmonaire, de préférence l'obstruction récurrente des voies respiratoires (rao), la maladie pulmonaire obstructive associée aux pâturages d'été (spaopd), et une maladie inflammatoire des voies respiratoires (iad).
Patent CS-254985-B2 (CS)
Title: Tag
Inventor: COHR LINDSAY W J
IPC: A01K11/00
Filed: 1985-04-19
Abstract: A one piece tag formed from a resilient plastics material comprises a mounting member (12) and a pair of panels (10, 11) attached thereto. The mounting member (12) has a pair of limb portions (12a) coupled together by an intermediate portion (13). A panel (10, 11) extends from the end of each limb portion (12a). 
     Coupling means (14) is provided adjacent the free end of one panel and an applicator tool can engage the tag via the coupling means. The panel is thus able to be forced through an object, such as the ear of an animal, by the applicator so that the intermediate portion (13) resides within the opening formed in the object and a panel lies either side of the opening.
Patent CS-244108-B2 (CS)
Title: Leno thread's feed device for weaving machine
Inventor: KOCH BERNHARD R
IPC: D03D49/14
Filed: 1980-06-11
Abstract: The crossing thread supply system for the weaving machine employs a rotatable bobbin carrier and a thread tensioning means for controlling a thread pay-out from a bobbin on the carrier as a function of thread tension. The tensioning means employs a control lever which is pivotable under the influence of the paid-out thread and a pivoting lever which engages via a pawl with a ratchet wheel connected to the bobbin carrier. The control lever serves to pivot the pivoting lever when moved to an innermost position. This disengages the pawl from the ratchet wheel to permit indexing of the ratchet wheel and bobbin carrier.
Patent CS-219326-B2 (CS)
Title: Paper with good absorption and resistance in respect of alkalis
Inventor: JONES NEWLYN
IPC: D21H27/00
Filed: 1977-06-27
Abstract: Fibrous paper webs of high water absorbency and improved alkaline wet tensile strength are obtained by treating the fibers prior to web formation or subsequent to web formation with aqueous solutions of a water-soluble thermosetting reaction product of a polyamide and an epichlorohydrin, a water-soluble nonviscose film-forming material such as hydroxy ethyl cellulose and a water-soluble polyethylene imine. The resultant absorbent sheet material maintains its absorbency upon aging, exhibits high wet caustic strength and can be used in the manufacture of tea bags or food casings.
Patent CS-212750-B2 (CS)
Title: Throughflow regulating valve
Inventor: LUNDSGART HENNING B
IPC: F16K31/363
Filed: 1975-10-07
Abstract: A fluid flow control valve having a valve member which is urged away from a cooperating seat by the combined pressures at the valve inlet and outlet and urged towards the seat by fluid pressure prevailing in a chamber which is connected to the valve inlet or outlet, respectively, dependent upon whether an order signal requires the valve to close or to open. Connection between said chamber and the valve inlet and outlet is controlled by an auxiliary valve which in turn is actuated through pressure transmitting lines connected to the inlet and outlet via a switch valve actuated by the order signal.
Patent JP-2641881-B2 (JP)
IPC: F02B71/00
Filed: 1988-01-08
Granted: 1997-08-20
Abstract: A detonating impact tool 10 has a manual recycler that works by manually pressing the tool and a fastener 25 against a work piece 51 to push a front housing 12 into a main housing 11 against a compression spring 30. This charges a detonation chamber 15 with a fuel and air mixture that is precompressed and detonated to drive a piston 20 and its impact rod 22 forward, driving the fastener into the work piece. On completion of its impact stroke, the piston clears an exhaust port 31, allowing exhaust gases to escape through an exhaust passageway 32. Following this, purging air rushes in through inlet 27 as the exhaust gases collapse; and as the tool is retracted from the work piece, pumping seal 26 draws purging, cooling, and recharging air into detonation chamber 15 as front housing 12 is returned to its forward position by the spring.
Patent JP-3681776-B2 (JP)
IPC: A61K9/127
Filed: 1995-01-18
Granted: 2005-08-10
Abstract: Prodn. of liposomes or proliposomes comprises milling a mixt. suitable for their prodn. in an agitator-ball mill. The mill is a special type of ball mill in which homogenisation and size reduction is caused by forces which are transferred from the agitator to the freely moving balls, pref. made of glass, and thence to the material being processed.  The liposomes can be loaded with water or with vitamins, e.g. vitamins A, B complex, C, E and K, pharmaceuticals, e.g. diazepam, amphotericin B, econazole, corticoids, heparin and cisplatin as well as flavourants and odorants, e.g. citrus oil, peppermint oil, vanilla extract, cocoa flavour and tobacco flavour. In contrast to known procedures, including the use of rotor-stator homogenisation and liquid high-pressure homogenisation using e.g. microfluidisers or liquid slot nozzle homogenisers, the method can be operated readily on an industrial scale under mild conditions and using concentrated solns. to give prods. having a reproducible particle size in which any active agent present is uniformly dispersed.
Patent JP-2831191-B2 (JP)
IPC: B60C27/10
Filed: 1992-01-23
Granted: 1998-12-02
Abstract: This anti-skid device comprises a casing (4) which carries several radial arms (3), at the outer end of which there is arranged an anti-skid rolling path constituted by chains (21, 22). The latter are automatically put in place on the wheel (1) of the vehicle by an elastic member (5) acting in the direction of arrow F. The casing (4) further interacts with a lever (6) having an extension capable of interacting in a removable manner with means (7) for fastening to a wheel nut (15). The means for linking the lever to the casing are coincident with the elastic traction means (5). 
<IMAGE>
Patent AU-604087-B2 (AU)
Title: Primary biliary cirrhosis autoantigen
Inventor: COPPEL ROSS LEON
IPC: C12N9/10
Filed: 1987-12-16
Granted: 1990-12-06
Abstract: Isolated peptides and polypeptides exhibiting the antigenicity of the 70 kD mitochondrial autoantigen of primary biliary cirrhosis are provided. The peptides, polypeptides and antigenic fragments thereof are useful in the diagnosis and treatment of primary biliary cirrhosis.
Patent AU-563273-B2 (AU)
Title: Composition containing an essential fatty acid and niacin and/or a bile salt binder
Inventor: HORROBIN DAVID FREDERICK
IPC: A61K31/20
Filed: 1983-02-16
Granted: 1987-07-02
Abstract: A pharmaceutical composition comprises one or more essential fatty acids such as  gamma -linolenic acid in conjunction with a bile salt binder or niacin or both. The compositions may be administered to reduce blood cholesterol levels.
Patent AU-625431-B2 (AU)
Title: Improved interferon therapy
Inventor: CUMMINS JOSEPH M
IPC: A61K38/21
Filed: 1987-11-06
Granted: 1992-07-09
Abstract: Neoplastic disease, hyperallergenicity, autoimmune disorders characterized by chronic tissue degenerative inflammation and immuno-resistant viral infections are treated by the administration of interferon at a dosage of about 0.1 to about 5 IU/lb per day by contacting said interferon with oral/pharyngeal mucosa. Interferon is administered in solution or in a novel solid unitary dosage form adapted to be dissolved in saliva when placed in the mouth.
Patent AU-649789-B2 (AU)
Title: Sg(b)-1,4-galactanase and a DNA sequence
Inventor: DORREICH KURT
IPC: C12N15/80
Filed: 1992-02-06
Granted: 1994-06-02
Abstract: A partial amino acid sequence of a  beta -1,4-galactanase obtainable by means of Aspergillus aculeatus is described, and also a corresponding recombinant DNA sequence, vector and transformed host. Use of the  beta -1,4-galactanase or a pectinase preparation enriched with the  beta -1,4-galactanase for degradation or modification of plant cell walls is described.
Patent AU-700599-B2 (AU)
Title: Colorant preparation for producing masterbatches
Inventor: BOTT RAINER
IPC: C08J3/22
Filed: 1995-02-28
Granted: 1999-01-07
Abstract: Colouring compsn. (A) comprises 1 or more finely divided colouring agents (I) plus an additive (II) to improve flowability in an amorphous poly- alpha -olefin (III). (III) is made from at least 2 different monomers, including 1-butene at at least 25 wt.%, and melts at 70 - 150 degrees C.
Patent AU-681231-B2 (AU)
Title: Methods and compositions for the treatment of a host with a cellular proliferative disease
Inventor: BROWN DENNIS M
IPC: A61K33/243
Filed: 1994-12-28
Granted: 1997-08-21
Abstract: Methods and compositions are provided for the treatment of a host with a cellular proliferative disease, particularly a neoplasia. In the subject methods, a pharmaceutically acceptable, substantially anhydrous, injectable semi-solid composition which acts as a depot for a cytostatic agent, is administered to a lesion of the disease, particularly intralesionally. The subject compositions comprise a water immiscible, fatty acid ester matrix and a cytostatic agent.
Patent AU-733123-B2 (AU)
Title: Device and method for cooling casting belts
Inventor: WYATT-MAIR GAVIN F
IPC: B22D11/06
Filed: 1998-11-20
Granted: 2001-05-10
Abstract: Method and device for cooling belts of single or twin belt casters. The belt is cooled by a liquid which is contacted with the inner surface of the belt by a system of feed tubes and collection tubes. Liquid is passed out the feed tube, into a channel that communicates with the inner surface of the heated belt, the belt is cooled, and the liquid is removed through collection tubes with a vacuum assist.
Patent AU-757043-B2 (AU)
Title: A clutch mechanism
Inventor: DYSON JAMES
IPC: A47L5/30
Filed: 1998-12-08
Granted: 2003-01-30
Abstract: The invention provides a clutch mechanism (200) having a driven pulley (32) and a drive pulley (34) to which a load is applied, the clutch mechanism (200) having an engaged position in which torque applied in use to the driven pulley (32) is transmitted to the drive pulley (34), and a disengaged position in which torque applied in use to the driven pulley (32) is not transmitted to the drive pulley (34), wherein the clutch mechanism (200) also has override means (238, 242) by which at least a proportion of the torque applied to the driven pulley (32) is absorbed when the load applied to the drive pulley (34) exceeds a predetermined value. The override means comprising a pair of detent plates (238, 242), and at least one ball-bearing (248) being held captive between the detent plates (248, 242).
Patent AU-650750-B2 (AU)
Title: Water-in-oil emulsions containing hydroxylamine
Inventor: HEITNER HOWARD IVAN
IPC: B01J13/00
Filed: 1992-05-22
Granted: 1994-06-30
Abstract: Water-in-oil emulsions are disclosed wherein the continuous phase comprises an oil and an emulsifier and the discontinuous phase comprises an aqueous solution of a hydroxylamine or an at least partially neutralized hydroxylamine salt.
Patent AU-569255-B2 (AU)
Title: Separating fatty acids
Inventor: CLEARY MICHAEL TERENCE
IPC: C07C57/12
Filed: 1983-09-08
Granted: 1988-01-28
Abstract: Oleic acid is separated from a feed mixture comprising oleic acid and linoleic acid by contacting the mixture at separation conditions with a molecular sieve comprising silicalite, thereby selectively retaining the oleic acid, removing the linoleic acid and recovering the oleic acid from the molecular sieve by displacement with a displacement fluid. The feed mixture may also contain rosin acids, in which case a first molecular sieve comprising silicalite is used to separate the fatty acids from the rosin acids. It is preferred that the displacement fluid comprise a liquid having a high polarity index and that the molecular sieve comprise silicalite dispersed in a silica matrix. A particularly preferred and novel molecular sieve comprises silicalite in a silica matrix and derived from a precursor comprising silicalite powder dispersed in colloidal amorphous silica, said precursor having been gelled and then treated in a manner effecting substantially complete elimination of hydroxyl groups on the molecular sieve.
Patent AU-704019-B2 (AU)
Title: Selective herbicide composition
Inventor: GLOCK JUTTA
IPC: A01N33/24
Filed: 1995-06-01
Granted: 1999-04-15
Abstract: Herbicidal compsn. for the selective control of weeds in crops contains: a) a N,N-disubstd. aniline herbicide (I); b) a chlorinated acetamide herbicide antagonist (antidote) of formula R-CHYCl (II); and c) inert carriers and additives. Ro = Me or Et; R = gp. of formula (a)-(j); Y = Cl; or H when R = gp. (g); R1-R8 = H or alkyl, alkoxy or haloalkyl with up to 4C; R9 = 1-4C alkyl or halo; R10 = halo; R11,R12 = H or 1-4C alkyl; Q = 1-4C alkylene opt. substd. by alkyl; R13 = H; 1-5C hydrocarbyl opt. substd. by halo, CN or CF3 or by 1 or more alkoxy; 3-8C cycloalkyl opt. substd. by 1-4C alkyl; 1-4C alkyl di-substd. by 1-4C alkoxy or substd. by 1,3-dioxolan-2- or 4-yl, 1,3-dioxan-2-yl, furyl or tetrahydrofuryl; -NHCO2R01; -CH2CO2R01; -CH(CH3)CO2R01; or -CH(R02)-C(R03)=NO_R04; R01 = 1-3C alkyl or allyl; R02,R03 = H or 1-4C alkyl; R04 = H or alkyl, alkenyl or alkynyl with up to 4C; R14 = H; halo; alkyl, alkoxy, alkenyloxy or alkynyloxy with up to 4C; dioxymethylene; or 1-4C alkyl substd. by CN; P' = 1-4C alkyl, 2-4C alkenyl, 2-4C alkynyl, 3-8C cycloalkyl; or 1-4C alkyl substd. by alkoxy, alkenyloxy, alkynyloxy, alkylthio, alkenylthio, alkynylthio, alkylsulphinyl or alkylsulphonyl with up to 4C, halo, CN, 2,2-di(1-4C alkoxy), 1,3-dioxolan-2-yl, 1,3-dioxolan-4-yl (opt. 2,2-disubstd. by 1-4C alkyl), 1,3-dioxan-2-yl, 2-benzopyranyl or tetrahydrofuryl; 1-4C alkoxycarbonyl; or 2-4C alkenyloxycarbonyl; or (P-X) = 1-4C haloalkyl; X = O,S,SO or SO2; n = 1-3; A = 1-8C hydrocarbyl opt. substd. by alkoxy, alkylthio, F, CN or haloalkyl; R15,R16 = OH, alkyl, alkoxy, alkenyloxy or alkynyloxy with up to 4C; aryl; 2-4C haloalkoxy; 2-8C alkoxyalkoxy; 1-4C alkoxy substd. by CN or Ph; or aryloxy opt. substd. by halo, CN, NO2 or 1-4C alkoxy; R17 = H; 1-4C alkyl; or Ph opt. substd. by halo, CN, NO2 or 1-4C alkoxy; R18 = H or 1-4C alkyl; R19 = H; -COCX1X2-R06; 2-4C alkenoyl substd. by halo; -COOR07; -COR08; alkyl or alkenyl with up to 4C; or Ph-1-4C alkyl opt. ring-substd. by halo, CN, NO2 or 1-4C alkoxy; R20 = H or alkyl, alkenyl or alkynyl with up to 4C; R06 = H; halo; or 1-6C alkyl; R07 = 1-4C alkyl or Ph-1-4C alkyl opt. ring-substd. by halo, CN, NO2 or 1-4C alkoxy; R08 = alkyl, alkenyl or alkynyl with up to 4C; Ph; or Ph-1-4C alkyl opt. ring-substd. by halo, CN, NO2 or 1-4C alkoxy; X1,X2 = H or halo; or R21 = Me; Et; Pr; 1-methylethyl; 2-propenyl; 2-butenyl; 1,1-dimethyl-2-propenyl; 2-propynyl; or 2-methyl-2-propynyl; R22-R25 = H or Me; R33,R34 = alkyl or alkenyl with up o 6C; or R33 and R34 together form a gp. of formula (k)-(n); R35,R36 = H or 1-6C alkyl; R37,R38 = H or 1-4C alkyl; or R37 + R 38 = -(CH2)5-; R39 = H; 1-4C alkyl; or furan-2-yl; R40-R55 = H or 1-4C alkyl. (I) is known from US 5002606. (II) is known from US 4971618, US 3959304, US 4256481, US 4708735, EP 149974, EP 304409, EP 31686, EP 54278, EP23305, US 4846880, EP 143078, EP 163607, EP 126710 and DE 2948535.
Patent AU-745438-B2 (AU)
Title: Intelligent network
Inventor: RIETKERK PAUL
IPC: H04M3/42
Filed: 1999-01-05
Granted: 2002-03-21
Abstract: Intelligent network (IN), comprising at least one Service Switching Point, SSP (2), at least one Service Control Point, SCP (3), one or more Intelligent Peripherals, IPs (5), and/or one or more Voice Response Systems, VRSs (4), which IN is capable of interacting with a PSTN or ISDN (1). The essence of the concept is an additional interface, in the form of a control member (6), between the IPs and/or VRs on one side and the Service Control Point(s) on the other side. Such makes it possible that the (advanced) IPs and VRSs are capable of exchanging all sorts of information with the SCP, without the IPs or VRSs consequently being occupied for an extended period of time. As a result, the SCP may dispose of (additional) information which in a regular IN cannot be made available to the SCP(s).
Patent AU-768071-B2 (AU)
Title: Low profile stent and graft combination
Inventor: VONESH MICHAEL J
IPC: A61F2/82
Filed: 2000-01-21
Granted: 2003-12-04
Abstract: Large diameter self-expanding endoprosthetic devices, such as stents and stent grafts for delivery to large diameter vessels, such as the aorta, are disclosed having very small compacted delivery dimensions. Devices with deployed dimensions of 26 to 40 mm or more are disclosed that are compacted to extremely small dimensions of 5mm or less, enabling percutaneous delivery of said devices without the need for surgical intervention. Compaction efficiencies are achieved by combining unique material combinations with new forms of restraining devices, compaction techniques, and delivery techniques. These inventive devices permit consistent percutaneous delivery of large vessel treatment devices. Additionally, small endoprosthetic devices are disclosed that can be compacted to extremely small dimensions for delivery through catheter tubes of less than 1 mm diameter.
Patent AU-680403-B2 (AU)
Title: A method of producing metallic magnesium, magnesium oxide or a refractory material
Inventor: ENGELL JOHN
IPC: C01F5/00
Filed: 1992-11-16
Granted: 1997-07-31
Abstract: PCT No. PCT/DK92/00339 Sec. 371 Date Jul. 13, 1995 Sec. 102(e) Date Jul. 13, 1995 PCT Filed Nov. 16, 1992 PCT Pub. No. WO94/11539 PCT Pub. Date May 26, 1994Metallic magnesium and pure magnesium oxide are produced by carbothermal reduction of starting materials such as magnesium oxide containing minor amounts of oxides of Fe, Si, Ca and Al, and/or magnesium silicate minerals, such as olivine, at subatmospheric pressure. Metallic magnesium is evaporated from a reduction zone and pure metallic magnesium and pure magnesium oxide are precipitated in a second condensation zone. Si is partly evaporated as SiO which is precipitated in a first condensation zone upstream the second condensation zone, partly converted to SiC and an alloy of Si and Fe in the reaction mixture. The starting materials may also be processed by a method wherein their magnesium component is converted to magnesium oxide in the reaction mixture, while the remaining components are converted to SiC and an alloy of Si and Fe. Au and valuable siderophilic elements may be recovered by leaching the alloy of Si and Fe.
Patent AU-695458-B2 (AU)
Title: Genetic therapeutic treatment of diseases of the central nervous system (CNS) with a cell-specific active compound which is dependent on the cell cycle
Inventor: SEDLACEK HANS-HARALD
IPC: A61K38/55
Filed: 1995-08-25
Granted: 1998-08-13
Abstract: PCT No. PCT/EP95/03370 Sec. 371 Date Apr. 18, 1997 Sec. 102(e) Date Apr. 18, 1997 PCT Filed Aug. 25, 1995 PCT Pub. No. WO96/06940 PCT Pub. Date Mar. 7, 1996A DNA sequence for the gene therapy of tumors is described. In its essential elements, the DNA sequence is composed of an activator sequence, a promoter module and a gene for the active substance. The activator sequence is activated, in a cell-specific manner, in proliferating endothelial cells or in cells which are adjacent to these endothelial cells. This activation is regulated by the promoter module in a cell cycle-specific manner. The active substance is an inhibitor of angiogenesis or a cytostatic or cytotoxic molecule. The DNA sequence is inserted into a viral or non-viral vector which is supplemented with a ligand which possesses affinity for the activated endothelial cell.
Patent AU-703231-B2 (AU)
Title: A process for the preparation of a stable, homogeneous, extract which is free or nearly free from secondary reaction products
Inventor: KREUTER MATHIAS-HEINRICH
IPC: A61K36/00
Filed: 1997-09-03
Granted: 1999-03-18
Abstract: Preparation of plant extracts (I) comprises (a1) extracting whole, dried or prepared plant material with a solvent in the presence of an agent (A) which improves the solubility of ≥ 1 product of extraction, increases the viscosity of the extract, affects the partial pressure of ≥ 1 extract component, reduces any enzymatic reactions, reduces any effects of sedimentation or flotation and (a2) separating any insoluble material and removing the solvent or (b1) extracting the material with a solvent, (b2) separating any insoluble material, (b3) mixing the extract with (A) and removing the solvent. The extraction is preferably effected at < 70 degrees C and the product dried or 5-20 (preferably 12-15) wt.% solvent added, preferably water, glycerol, propylene glycol or polyethylene glycol and a emulsifier, stabiliser, antioxidant, colour, flavour, dispersing agent, anticaking agent, hygroscopicity reducing agent, an inert support agent preferably polyethylene glycol, polyglycerine fatty acid esters, lecithins, silicone oils, sorbates, polysorbates, waxes, glycerides, fatty acids or paraffins.
Patent AU-705883-B2 (AU)
Title: Pyridopyrimidones, quinolines and fused N-heretocycles as bradykinin antagonists
Inventor: OKU TERUO
IPC: C07D471/04
Filed: 1995-10-25
Granted: 1999-06-03
Abstract: This invention relates to a compound of the formula: wherein Z is a group of the formula: in which X1 is N or C-R1, X2 is N or C-R9, X3 is N or C-R2, R1 is lower alkyl, R2 is hydrogen, lower alkyl, etc., R9 is hydrogen or lower alkyl, R3 is halogen, etc., R4 is halogen, etc., R5 is a group of the formula: A is lower alkylene, and Y is O, etc., and pharmaceutically acceptable salts thereof, to processes for preparation thereof, to a pharmaceutical composition comprising the same, and to methods to using the same therapeutically in the prevention and/or the treatment of bradykinin or its analogues mediated diseases in human being or animals.
Patent AU-754228-B2 (AU)
Title: Heparanase specific molecular probes and their use in research and medical applications
Inventor: PECKER IRIS
IPC: C12Q1/6886
Filed: 1999-04-29
Granted: 2002-11-07
Abstract: A variety of heparanase specific molecular probes which can be used for research and medical applications including diagnosis and therapy. Specific applications include the use of a heparanase specific molecular probe for detection of the presence, absence or level of heparanase expression; the use of a heparanase specific molecular probe for therapy of a condition associated with expression of heparanase; the use of a heparanase specific molecular probe for quantification of heparanase in a body fluid; the use of a heparanase specific molecular probe for targeted drug delivery; and the use of a heparanase specific molecular probe as a therapeutic agent.
Patent AU-703119-B2 (AU)
Title: Thiol compounds
Inventor: HAYASHI KAZUHIKO
IPC: C07D417/12
Filed: 1995-12-12
Granted: 1999-03-18
Abstract: This invention relates to 3-mercapto-1-(1, 3-thiazolin-2-yl)azetidine represented by the following formula and its acid addition salts <CHEM> and to the production process therefor. The above compounds are useful as intermediates for preparing carbapenem compounds, which have strong antibacterial activity, with convenience and high yield.
Patent AU-755067-B2 (AU)
Title: Immunoregulator
Inventor: KHAN NISAR AHMED
IPC: A61K38/24
Filed: 1999-05-20
Granted: 2002-12-05
Abstract: The invention relates to the field of immunology, more specifically to the field of immune-mediated disorders such as allergies, auto-immune disease, transplantation-related disease or inflammatory disease. The invention provides among others an immunoregulator (IR), use of an IR in preparing a pharmaceutical composition for treating an immune-mediated disorder, a pharmaceutical composition and a method for treating an immune-mediated disorder.